These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis. Gray E; Thompson AG; Wuu J; Pelt J; Talbot K; Benatar M; Turner MR Ann Clin Transl Neurol; 2020 Aug; 7(8):1296-1306. PubMed ID: 32666680 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of Chitotriosidase and CC-Chemokine Ligand 18 as Biomarkers of Microglia Activation in Amyotrophic Lateral Sclerosis. Martinez-Merino L; Iridoy M; Galbete A; Roldán M; Rivero A; Acha B; Irún P; Canosa C; Pocoví M; Mendioroz M; Jericó I Neurodegener Dis; 2018; 18(4):208-215. PubMed ID: 30134252 [TBL] [Abstract][Full Text] [Related]
8. Exploiting the role of CSF NfL, CHIT1, and miR-181b as potential diagnostic and prognostic biomarkers for ALS. Gagliardi D; Rizzuti M; Masrori P; Saccomanno D; Del Bo R; Sali L; Meneri M; Scarcella S; Milone I; Hersmus N; Ratti A; Ticozzi N; Silani V; Poesen K; Van Damme P; Comi GP; Corti S; Verde F J Neurol; 2024 Dec; 271(12):7557-7571. PubMed ID: 39340541 [TBL] [Abstract][Full Text] [Related]
9. Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase. Oeckl P; Weydt P; Steinacker P; Anderl-Straub S; Nordin F; Volk AE; Diehl-Schmid J; Andersen PM; Kornhuber J; Danek A; Fassbender K; Fliessbach K; ; Jahn H; Lauer M; Müller K; Knehr A; Prudlo J; Schneider A; Thal DR; Yilmazer-Hanke D; Weishaupt JH; Ludolph AC; Otto M J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):4-10. PubMed ID: 30224549 [TBL] [Abstract][Full Text] [Related]
10. Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis? Gille B; De Schaepdryver M; Dedeene L; Goossens J; Claeys KG; Van Den Bosch L; Tournoy J; Van Damme P; Poesen K J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1338-1346. PubMed ID: 31175169 [TBL] [Abstract][Full Text] [Related]
11. CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia. Abu-Rumeileh S; Steinacker P; Polischi B; Mammana A; Bartoletti-Stella A; Oeckl P; Baiardi S; Zenesini C; Huss A; Cortelli P; Capellari S; Otto M; Parchi P Alzheimers Res Ther; 2019 Dec; 12(1):2. PubMed ID: 31892365 [TBL] [Abstract][Full Text] [Related]
12. Association between cerebrospinal fluid chitotriosidase level and amyotrophic lateral sclerosis: a systematic review. Khorshidi Z; Adibi I; Ghasemi M Horm Mol Biol Clin Investig; 2024 Oct; ():. PubMed ID: 39344189 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study. Gagliardi D; Faravelli I; Meneri M; Saccomanno D; Govoni A; Magri F; Ricci G; Siciliano G; Pietro Comi G; Corti S J Cell Mol Med; 2021 Apr; 25(8):3765-3771. PubMed ID: 33609080 [TBL] [Abstract][Full Text] [Related]
20. Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis. Oeckl P; Weydt P; Thal DR; Weishaupt JH; Ludolph AC; Otto M Acta Neuropathol; 2020 Jan; 139(1):119-134. PubMed ID: 31701227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]